TherapeuticsMD, Inc. — Director's Dealing 2014

Nov 25, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2014-11-21

Reporting Person: Krassan Mitchell (EVP, Chief Strategy Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-11-21	Non-qualified stock option	$4.01	A	75000	Acquired	2024-11-20	Common Stock (75000)	Direct

Footnotes

F1: The shares underlying the option vest at a rate of 18,750 shares on the first, second, third and fourth anniversay date of the option.